Loading...
ProSomnus, Inc.
OSAAW•NASDAQ
Healthcare
Medical - Devices
$0.02
$-0.00(-6.40%)

Over the past four quarters, ProSomnus, Inc. demonstrated steady revenue growth, increasing from $6.93M in Q2 2023 to $7.46M in Q1 2024. Operating income reached -$1.79M in Q1 2024, maintaining a consistent -24% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$1.79M, reflecting operational efficiency. Net income rose to $3.44M, with EPS at $0.20. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan